Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Chifamba LV, Parlar SC, Somerville EN, Liu L, Yu E, Asayesh F, Ahmad J, Teferra M, Ruskey JA, Waters C, Monchi O, Dauvilliers Y, Dupré N, Timofeeva A, Emelyanov A, Pchelina S, Miliukhina I, Greenbaum L, Hassin-Baer S, Goldstein O, Radefeldt M, Bauer P, Beetz C, Dilliott AA, Beck JC, Senkevich K, ROPAD Study Group, Parkinson's Foundation PD GENEration Study, Klein C, Alcalay RN, Gan-Or Z.

Mov Disord · 2026-05-22

DOI: 10.1002/mds.70367PMID: 42175590

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Short-and long-term responsiveness of deep brain stimulation on motor and cognitive outcomes in GBA vs. Non-GBA parkinson's disease: a systematic review and meta-analysis of observational studies.

Gonzales Romero PF, Bermejo Rosado P, Paredes Torres F, Váscones-Román FF, Limbania D, Pichardo-Rojas D, Quispe-Vicuña C, Nuñez-Castellanos C, Yazdanian F, Warren AE, Pacheco-Barrios N, Rolston JD.

Neurosurg Rev · 2026-05-20

DOI: 10.1007/s10143-026-04331-9PMID: 42156595

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Shared and distinct lipid profiles in amygdala from sporadic and GBA-associated Parkinson's diseases.

Muñoz SS, Marlet FR, Dreier JE, Bilgin M, Schott K, Neergaard KBS, Bezard E, Dehay B, Jaunmuktane Z, Maeda K, Galvagnion C.

NPJ Parkinsons Dis · 2026-05-11

DOI: 10.1038/s41531-026-01383-yPMID: 42115606

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A novel insight into the risk of depression and anxiety onset in Parkinson's disease: the implications of GBA1 and LRRK2.

Yang D, Wang J, Huang H, Lin S, Liu Z, Zhang S, Xu J, Zhang B, Cai H, Lin H, Huang S, Chen G.

Parkinsonism Relat Disord · 2026-05-07

DOI: 10.1016/j.parkreldis.2026.108341PMID: 42114177

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

mTOR Inhibition Drives Mutation-Specific Remodeling of Lysosomal and Autophagic Pathways and GCase Activity in PBMC-Derived Macrophages from Patients with GBA1-Associated Parkinson's Disease.

Bezrukova A, Basharova K, Emelyanov A, Lavrinova A, Krapova A, Galkina E, Skudarnova E, Baydakova G, Miliukhina I, Zakharova E, Pchelina S, Usenko T.

Curr Issues Mol Biol · 2026-05-01

DOI: 10.3390/cimb48050473PMID: 42193078

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Clinical Trials in GBA1-Associated Parkinson's Disease: A Need for Molecular Classification.

Gan-Or Z.

Mov Disord · 2026-04-13

DOI: 10.1002/mds.70328PMID: 41975626

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Associations of Monocyte Glucocerebrosidase with Cognition and Cholinergic Innervation in GBA1 Parkinson's Disease.

Slingerland S, van der Zee S, van Ijzendoorn SCD, Slomp AC, Boertien JM, Meles SK, Kol A, Geerlings M, van Laar T.

Mov Disord · 2026-04-13

DOI: 10.1002/mds.70292PMID: 41969198

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Association between heterozygous GBA1 L444P carrier status and risk of Parkinson's disease: A systematic review and meta-analysis.

Jurecka A, Kim HK, Siegfried N, Zhao YC.

Mol Genet Metab · 2026-04-02

DOI: 10.1016/j.ymgme.2026.110112PMID: 41936135

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Generation and characterization of induced pluripotent stem cell lines from one Parkinson's disease patient carrying the GBA1 T369M variant and two variant-free controls.

Hosseini Bondarabadi M, Xu M, Slingerland S, de Leeuw J, Sommer I, Harmsen HJM, van Laar T, van Ijzendoorn SCD.

Stem Cell Res · 2026-04-01

DOI: 10.1016/j.scr.2026.103983PMID: 41932028

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Commentary: Pesticides and <i>GBA1</i> pathogenic variants in Parkinson's disease: An emerging and potentially dangerous association.

Schuh AF, Stefanis L.

J Parkinsons Dis · 2026-03-05

DOI: 10.1177/1877718x261430187PMID: 41784953

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

APOE, Aβ42, and tau differentially impact cognitive decline in Sporadic, GBA1 and LRRK2 Parkinson's disease.

Botta R, Locascio JJ, Ye R, Goodheart AE, Gomperts SN.

NPJ Parkinsons Dis · 2026-02-23

DOI: 10.1038/s41531-026-01290-2PMID: 41730900

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Parkinson's research with inclusion, diversity, and equity: exploring the experiences of LGBTQ+ caregivers of people living with Parkinson's disease.

Benson S, Castro B, Yamada C, Pharr JR, Kittle KR, Flatt JD.

J Gerontol B Psychol Sci Soc Sci · 2026-02-01

DOI: 10.1093/geronb/gbaf272PMID: 41454615

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

404 makale bulundu

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Short-and long-term responsiveness of deep brain stimulation on motor and cognitive outcomes in GBA vs. Non-GBA parkinson's disease: a systematic review and meta-analysis of observational studies.

Shared and distinct lipid profiles in amygdala from sporadic and GBA-associated Parkinson's diseases.

A novel insight into the risk of depression and anxiety onset in Parkinson's disease: the implications of GBA1 and LRRK2.

mTOR Inhibition Drives Mutation-Specific Remodeling of Lysosomal and Autophagic Pathways and GCase Activity in PBMC-Derived Macrophages from Patients with GBA1-Associated Parkinson's Disease.

Clinical Trials in GBA1-Associated Parkinson's Disease: A Need for Molecular Classification.

Associations of Monocyte Glucocerebrosidase with Cognition and Cholinergic Innervation in GBA1 Parkinson's Disease.

Association between heterozygous GBA1 L444P carrier status and risk of Parkinson's disease: A systematic review and meta-analysis.

Generation and characterization of induced pluripotent stem cell lines from one Parkinson's disease patient carrying the GBA1 T369M variant and two variant-free controls.

Commentary: Pesticides and <i>GBA1</i> pathogenic variants in Parkinson's disease: An emerging and potentially dangerous association.

APOE, Aβ42, and tau differentially impact cognitive decline in Sporadic, GBA1 and LRRK2 Parkinson's disease.

Parkinson's research with inclusion, diversity, and equity: exploring the experiences of LGBTQ+ caregivers of people living with Parkinson's disease.

Filtreler